FDA panel votes to loosen restrictions on unproven peptides amid safety concerns

An FDA advisory panel has voted to relax rules around a class of drugs that have become wildly popular online but remain largely unstudied in humans. The decision clears a regulatory path for specialized pharmacies to manufacture peptides like BPC-157, TB-500, and KPV—substances that have exploded across social media wellness communities and TikTok in recent years, marketed with claims about muscle building, anti-aging, and healing that lack scientific backing.

Peptides are short chains of amino acids, small proteins that our bodies naturally produce. They function as messengers, signaling cells to perform specific tasks, and they do have legitimate medical uses—treating diabetes, for instance. But the peptides gaining traction online exist in a regulatory gray zone. They are not illegal to purchase or possess, and they are widely available through internet retailers. Yet they are not approved for human use, which means they bypass the quality controls and safety standards that govern legitimate pharmaceutical manufacturing.

The panel's narrow vote represents a significant victory for Health Secretary Robert F. Kennedy, who has publicly declared himself a devoted advocate for these drugs and has made loosening restrictions on them a priority since taking office. Kennedy's push reverses the Biden administration's approach, when FDA officials determined that these peptides failed to meet safety requirements. The agency is not obligated to follow the panel's recommendation, but it historically does.

BPC-157, derived from stomach protein, has become one of the most sought-after peptides in the online wellness space. Influencers market it for gut health, tissue repair, and inflammation reduction. Animal studies have suggested potential benefits for muscle healing, but human clinical trials do not exist. The US Anti-Doping Agency has stated plainly that because the compound has not been extensively studied in people, no one knows what a safe dose looks like or whether there is any way to use it safely for any specific medical condition. The World Anti-Doping Agency classifies it as a banned substance in sports.

KPV follows a similar pattern—promoted for gut health, skin repair including acne treatment, and immune regulation, but without human safety data to support these claims. Both peptides have become especially popular among teenagers on TikTok, particularly boys, who encounter marketing language around "biohacking" and "looksmaxxing" that frames these unproven substances as shortcuts to physical transformation.

Panel member Elizabeth Rebello, a pharmacist and anesthesiologist, voted against loosening restrictions on BPC-157, citing the absence of efficacy data and unresolved safety concerns. Those who voted in favor reportedly invoked "the greater good" and "medical freedom" as justification. The panel composition itself raises questions: several members work for clinics or businesses that sell peptides, creating a potential conflict of interest as the group continues deliberating on additional compounds.

Health experts have warned against widespread use of these drugs, pointing to the lack of human clinical trials and the unknown long-term effects of substances being injected by people with no medical supervision. The peptides remain in a peculiar limbo—available everywhere online, marketed aggressively to young people, yet without any established safe dosing protocols or understanding of what harm they might cause over time. The FDA panel's vote moves them closer to legitimacy, even as the scientific foundation for their safety remains essentially empty.